-
HIV and AIDS CURE DR ROBERT...
-
Dr Robert Bob Beck. A remarkable man and seriously gifted individual. an expert in micro currents to...
-
Batteries
-
This General Chemistry lecture shows how to calculate the electric potential (voltage) for any elect...
-
Herpes Labialis treatment w...
-
This video illustrates the treatment of an early stage HSV lesion of the lower lip with the PerioLas...
-
BLUNT ABDOMINAL TRAUMA Surg...
-
USMLE Step 2 and 3 BLUNT ABDOMINAL TRAUMA algorithm lecture. Look out for book USMLE ALGORITHMS for ...
-
DALLAS HAIR LOSS NON-SCARRI...
-
DALLAS HAIR TRANSPLANT SURGEON, DR. SAMUEL LAM, LECTURES ON CAUSES OF NON-SCARRING, PATCHY HAIR LOSS...
medical-video  |
(0) (0 Votes)
|
Views: (481) Date: (13-09-09) Time: (00:51:16) |
Description: experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective. Stanford University School of Medicine: med.stanford.edu Stanford University Channel on YouTube: www.youtube.com ... medicine health disease therapy treatment research immune system ...